30 Stocks Moving in Monday’s Pre-Market Session
Gainers
AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday.
HC Wainwright & Co. Maintains Buy on CASI Pharmaceuticals, Lowers Price Target to $3
HC Wainwright & Co. analyst Sean Lee maintains CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and lowers the price target from $4 to $3.
This Day In Market History: New York Times Article Suggests Cancer Cure By Year 2000
Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date.
What Happened? On May 3, 1998, a front-page New York Times report suggested EntreMed was two years away from curing cancer in humans.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Baidu, iQIYI Explore Options After US SEC Added Them To Provisional List Pending Audit Review
Baidu Inc (NASDAQ:BIDU) explored options after the U.S. SEC added the Chinese search engine giant to a list of…
CASI Pharmaceuticals’s Return On Capital Employed Insights
According to data from Benzinga Pro, during Q4, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $9.16 million. Despite a 46.15% increase in earnings, the company posted a loss of $5.39 million.
Recap: CASI Pharmaceuticals Q4 Earnings
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q4 earnings results on Monday, March 28, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.